 ?您的位置：對照品 > 對照品 > 雜質(zhì)對照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：F595737 |
| 產(chǎn)品名稱：2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-ph |
| 產(chǎn)品CAS：163217-67-2 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標(biāo)準(zhǔn)品編號: |
F595737 |
| 名稱: |
2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-phenyl)-amide |
| 別名: |
4-Fluoro-α-(2-methyl-1-oxopropyl)-γ-oxo-β-phenyl-N-[4-(phenylmethoxy)phenyl]benzenebutanamide; 4-Methyl-3-oxo-N-(4-benzyloxyphenyl)-2-[1-phenyl-2-(4-fluorophenyl)-2-oxoethyl]pentamide; |
| CAS號: |
163217-67-2 |
| 分子式: |
C??H??FNO? |
| 外觀: |
白色固體 |
| 分子量: |
523.59 |
| 溶解度: |
Acetone, Chloroform, Dichloromethane, Ethyl Acetate |
| 種類: |
Standards; Miscellaneous; |
| 應(yīng)用: |
An intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia. |
| 參考文獻 |
|
|
|
|
|
|
![2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-ph](/uploads/allimg/191202/1_12020243329221.png "2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-ph")
